The post MLB Sees Dramatic Drop In PED Suspensions appeared on BitcoinEthereumNews.com. Performance enhancing drugs in Major League Baseball was once a regular headline story, but over several years, there has been a significant decline in PED suspensions and players seeking therapeutic use exemptions. getty Once a burning issue for Major League Baseball, the number of suspensions for players using performance-enhancing drugs – as well as therapeutic use exemptions for banned substances – has dropped dramatically in recent years. An annual report for 2025 shows that trend continuing. If you don’t recall Alex Sanchez of the Tampa Bay Rays in 2005, you’d be forgiven. But Sanchez has a unique place in the history of Major League Baseball. On January 3, 2005, he became the first player in history suspended for a violation of MLB’s drug testing policy, serving a 10-game suspension. In the first year of the Major League Drug Prevention and Treatment Program, which was reached between MLB and the MLB Players Association, a total of 12 players were suspended for PEDs. It would not be until the Biogenesis scandal of 2013 that the likes of Alex Rodriguez, Nelson Cruz, Ryan Braun, Jhonny Peralta, and more would push MLB PED suspensions to a historical high of 16. The specter of performance-enhancing substances will never leave the sport, but in recent years, there has been a significant decline in not just suspensions, but also in the allowance of therapeutic use exemptions (TUEs) for the use of what would usually be banned substances. Each year, MLB and the MLBPA release an annual report on drug testing in the league. The report is issued by an Independent Program Administrator; this year, Thomas M. Martin, Ph.D. For 2025, the total number of drug tests that were conducted totaled 11,700. Of those, 9.400 were urine samples. The number of dried blood spot samples that were collected… The post MLB Sees Dramatic Drop In PED Suspensions appeared on BitcoinEthereumNews.com. Performance enhancing drugs in Major League Baseball was once a regular headline story, but over several years, there has been a significant decline in PED suspensions and players seeking therapeutic use exemptions. getty Once a burning issue for Major League Baseball, the number of suspensions for players using performance-enhancing drugs – as well as therapeutic use exemptions for banned substances – has dropped dramatically in recent years. An annual report for 2025 shows that trend continuing. If you don’t recall Alex Sanchez of the Tampa Bay Rays in 2005, you’d be forgiven. But Sanchez has a unique place in the history of Major League Baseball. On January 3, 2005, he became the first player in history suspended for a violation of MLB’s drug testing policy, serving a 10-game suspension. In the first year of the Major League Drug Prevention and Treatment Program, which was reached between MLB and the MLB Players Association, a total of 12 players were suspended for PEDs. It would not be until the Biogenesis scandal of 2013 that the likes of Alex Rodriguez, Nelson Cruz, Ryan Braun, Jhonny Peralta, and more would push MLB PED suspensions to a historical high of 16. The specter of performance-enhancing substances will never leave the sport, but in recent years, there has been a significant decline in not just suspensions, but also in the allowance of therapeutic use exemptions (TUEs) for the use of what would usually be banned substances. Each year, MLB and the MLBPA release an annual report on drug testing in the league. The report is issued by an Independent Program Administrator; this year, Thomas M. Martin, Ph.D. For 2025, the total number of drug tests that were conducted totaled 11,700. Of those, 9.400 were urine samples. The number of dried blood spot samples that were collected…

MLB Sees Dramatic Drop In PED Suspensions

2025/12/03 21:41

Performance enhancing drugs in Major League Baseball was once a regular headline story, but over several years, there has been a significant decline in PED suspensions and players seeking therapeutic use exemptions.

getty

Once a burning issue for Major League Baseball, the number of suspensions for players using performance-enhancing drugs – as well as therapeutic use exemptions for banned substances – has dropped dramatically in recent years. An annual report for 2025 shows that trend continuing.

If you don’t recall Alex Sanchez of the Tampa Bay Rays in 2005, you’d be forgiven. But Sanchez has a unique place in the history of Major League Baseball. On January 3, 2005, he became the first player in history suspended for a violation of MLB’s drug testing policy, serving a 10-game suspension. In the first year of the Major League Drug Prevention and Treatment Program, which was reached between MLB and the MLB Players Association, a total of 12 players were suspended for PEDs. It would not be until the Biogenesis scandal of 2013 that the likes of Alex Rodriguez, Nelson Cruz, Ryan Braun, Jhonny Peralta, and more would push MLB PED suspensions to a historical high of 16.

The specter of performance-enhancing substances will never leave the sport, but in recent years, there has been a significant decline in not just suspensions, but also in the allowance of therapeutic use exemptions (TUEs) for the use of what would usually be banned substances.

Each year, MLB and the MLBPA release an annual report on drug testing in the league. The report is issued by an Independent Program Administrator; this year, Thomas M. Martin, Ph.D.

For 2025, the total number of drug tests that were conducted totaled 11,700. Of those, 9.400 were urine samples. The number of dried blood spot samples that were collected and analyzed for the presence of human growth hormone (hGH) was 2,300.

Of those tests, two resulted in adverse findings that led to suspensions. In all cases, players are retested if there are adverse findings. Should the findings remain and fall under the substances that result in suspension, a player can appeal the suspension. Therefore, when a suspension is announced, it is a considerable period of time after the player tests positive for PEDs.

For 2025, there were two players suspended for violating the drug program:

On May 18th, José Alvarado received an 80-game suspension without pay after testing positive for exogenous Testosterone. On May 31st, Jurickson Profar received an 80-game suspension without pay after testing positive for Chorionic Gonadotrophin (hCG). In both cases, the suspensions were for performance-enhancing substances.

Therapeutic Use Exemptions For Otherwise Banned Substances

The league and MLBPA have allowed a system in which players, through a doctor’s care, and apply for what is called a Therapeutic Use Exemption, or TUEs. The TUEs is granted after comprehensive medical documentation to prove the medical need for the medication and demonstrate that the treatment only returns the athlete to a normal level of health, rather than providing an unfair advantage. In the vast majority of the TUEs granted each year, the exemption is made for Attention Deficit Hyperactivity Disorder (ADHD) medications. These medications are often amphetamine derivatives, and given that amphetamines are banned in MLB, the player would need an exemption to use such meds to address ADHD.

In years past, the number of ADHD TUEs has reached over 100, which raised the question as to whether there was a fundamental loophole in the drug testing program.

But over the years, these numbers have declined dramatically. For 2025, there was a total of 57 TUEs granted, with 54 for ADHD, along with one each granted for hypertension, sleep disorder, and hormone function. In all cases, the players granted TUEs are not released in the annual report. The drug testing program does not allow for therapeutic use exemptions for human growth hormone.

The 57 total therapeutic use exemptions in 2025 is a -37% drop from the 91 granted in 2020, and shows the drop over just the past six years. While there will likely never be a day when there are no suspensions and no therapeutic use exemptions, for now, at least within the drug program, Major League Baseball is about as free from PEDs as it may ever be.

The table below shows the number of PED suspensions, the total number of therapeutic use exemptions, and the number of those that are ADHD related from 2020 to 2025.

Graphical representation of MLB drug suspension, TUEs, and those that are for ADHD

Maury Brown

Source: https://www.forbes.com/sites/maurybrown/2025/12/03/mlb-sees-dramatic-drop-in-ped-suspensions/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

This Exclusive Cayman Getaway Tastes As Good As It Feels

This Exclusive Cayman Getaway Tastes As Good As It Feels

The post This Exclusive Cayman Getaway Tastes As Good As It Feels appeared on BitcoinEthereumNews.com. 1OAK’s Sand Soleil sits on Grand Cayman’s iconic Seven Mile Beach 1OAK Exhausted and professionally burnt out, I arrived at 1OAK’s Sand Soleil in search of the type of restoration that could still my mind and get me writing again. The seven-day culinary experience was a no-brainer for me as a food writer. The integration of an epicurean getaway with pure Cayman luxury seemed to be the perfect spark for my creativity—private chef dinners, deep dives into Caribbean flavors, and hands-on masterclasses, all located within a serene, oceanfront villa. I had finally arrived. With the last rays of the sun setting behind Grand Cayman’s famous Seven Mile Beach, casting a warm golden glow across the water, I tasted Chef Joe Hughes’ ceviche for the first time—cubes of wahoo cured in lime, with charred pineapple and a subtle, nutty crunch. Chef Joe Hughes’ love for bright, Asian-inspired flavours came through in this wahoo tataki layered with Vietnamese herbs, ripe papaya and mango, cashew and cilantro, all brought together with a nuoc cham. Jamie Fortune Something softened. For the first time in months, I began to feel present. Sophia List, the brainchild of the 1OAK experience, heard me well. With an intuition honed by years of curating luxury, she matched me with what she called “a vision realized.” List told me Sand Soleil—like the other 1OAK homes on Seven Mile Beach and in West Bay—was created to feel like a real sanctuary. For her, it’s the laid-back alternative to a busy hotel, a place where you get privacy and elegance without any fuss. “We wanted to introduce the Cayman Islands to something truly special—an ultra-luxury experience that combines exquisite design, maximum privacy, and a sense of calm,” she shared as she guided me through the four-bedroom villa. “We are so excited to…
Share
BitcoinEthereumNews2025/12/06 14:01
Maxi Doge Momentum Builds While BlockDAG’s Gamified Presale Nears $410M

Maxi Doge Momentum Builds While BlockDAG’s Gamified Presale Nears $410M

The post Maxi Doge Momentum Builds While BlockDAG’s Gamified Presale Nears $410M appeared on BitcoinEthereumNews.com. The Maxi Doge token has surged into the spotlight, drawing over $2.2 million as traders bet on a launch-week rally. Buzz around the Maxi Doge price is spreading across crypto forums and meme coin groups, with early buyers hoping to catch a fast move once listings open. It has become one of the most talked-about meme presales of the year, built on viral branding and social momentum. BlockDAG (BDAG) has been moving in a different way, raising nearly $410 million by rewarding participation instead of chasing quick hype. Its referral-driven payouts and competitive buying model have transformed its presale into a system where engagement produces measurable growth. With rising attention, the stage is set for a clash between short-term hype and structured long-term scale. Can Maxi Doge Turn Hype Into a Real Breakout? The Maxi Doge token has raced past $2.2 million in its presale, making it one of the most talked-about meme launches of the season. The buzz surrounding the Maxi Doge price has spread rapidly across crypto forums, Telegram groups, and social channels as early traders look to secure a low entry before listings go live. Much of this excitement comes from its unapologetically meme-heavy branding, which has helped it stand out in an oversaturated market. Supporters argue that this type of energy is exactly what fuels breakout moments. They believe if Maxi Doge can maintain engagement in its first exchange debut, the Maxi Doge price could see a sharp surge driven by hype and opening-week liquidity. Skeptics warn that meme coins often lose steam as quickly as they gain it, but for now, the Maxi Doge token has proven its ability to spark attention and rally an eager community. Why BlockDAG’s Presale Rewards Keep Traders Coming Back While meme projects chase fleeting hype, BlockDAG has built its…
Share
BitcoinEthereumNews2025/09/21 23:00
How Pros Buy Bitcoin Dips With DCA Like Institutions

How Pros Buy Bitcoin Dips With DCA Like Institutions

The post How Pros Buy Bitcoin Dips With DCA Like Institutions appeared on BitcoinEthereumNews.com. “Buy every dip.” That’s the advice from Strike CEO Jack Mallers. According to Mallers, with quantitative tightening over and rate cuts and stimulus on the horizon, the great print is coming. The US can’t afford falling asset prices, he argues, which translates into a giant wall of liquidity ready to muscle in and prop prices up. While retail has latched onto terms like “buy the dip” and “dollar-cost averaging” (DCA) for buying at market lows or making regular purchases, these are really concepts borrowed from the pros like Samar Sen, the senior vice president and head of APAC at Talos, an institutional digital asset trading platform. He says that institutional traders have used these terms for decades to manage their entry points into the market and build exposure gradually, while avoiding emotional decision-making in volatile markets. Source: Jack Mallers Related: Cryptocurrency investment: The ultimate indicators for crypto trading How institutions buy the dip Treasury companies like Strategy and BitMine have become poster children for institutions buying the dip and dollar-cost averaging (DCA) at scale, steadfastly vacuuming up coins every chance they get. Strategy stacked another 130 Bitcoin (BTC) on Monday, while the insatiable Tom Lee scooped up $150 million of Ether (ETH) on Thursday, prompting Arkham to post, “Tom Lee is DCAing ETH.” But while it may look like the smart money is glued to the screen reacting to every market downturn, the reality is quite different. Institutions don’t use the retail vocabulary, Samar explains, but the underlying ideas of disciplined accumulation, opportunistic rebalancing and staying insulated from short-term noise are very much present in how they engage with assets like Bitcoin. The core difference, he points out, is in how they execute those ideas. While retail investors are prone to react to headlines and price charts, institutional desks rely…
Share
BitcoinEthereumNews2025/12/06 13:53